blog/
18 pages · Updated July 26, 2026
Pages
- Expanding the Immuno-oncology Toolbox with an AI-discovered Target and Novel Inhibitor | Insilico Medicine
- End-to-End AI-Driven Design of a First-in-Class PKMYT1 PROTAC Using Chemistry42
- PCC | Insilico Medicine
- FIH | Insilico Medicine
- Automated data preparation for QSAR modeling
- Teaching AI the Language of Molecules
- Science42: DORA| Blog | Insilico Medicine
- Covering Patent Holes: How LEGION Uses AI to Block Competition in Chemical Space
- PCC for Kidney Fibrosis | Insilico Medicine
- First Generative AI Drug Begins Phase II Trials with Patients | Insilico Medicine
- AI for Longevity and Prosperity | Insilico Medicine
- A Phase 2 Readout Generates Excitement for the Potential of AI-Driven Drug Discovery
- IPF – Phase 1 | Insilico Medicine
- ReLEHF | Insilico Medicine
- Drug Discovery Record | Insilico Medicine
- Rare Diseases | Insilico Medicine
- Blog | Insilico Medicine
- Chemistry42 at NVIDIA GTC 2021